Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+34.6%
5Y CAGR+15.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+34.6%/yr
Quarterly compound
5Y CAGR
+15.4%/yr
Recent acceleration
Percentile
P85
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 55.02% |
| Q3 2025 | 3.41% |
| Q2 2025 | 42.73% |
| Q1 2025 | -18.68% |
| Q4 2024 | 19.70% |
| Q3 2024 | 4.05% |
| Q2 2024 | 5.20% |
| Q1 2024 | 15.29% |
| Q4 2023 | -4.00% |
| Q3 2023 | 10.24% |
| Q2 2023 | 19.66% |
| Q1 2023 | 30.14% |
| Q4 2022 | 22.58% |
| Q3 2022 | -37.01% |
| Q2 2022 | 570.91% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 26.91% |
| Q3 2020 | -7.07% |
| Q2 2020 | -57.12% |
| Q1 2020 | 145.76% |
| Q4 2019 | 36.18% |
| Q3 2019 | -0.75% |
| Q2 2019 | -13.25% |
| Q1 2019 | 0.71% |
| Q4 2018 | 97.48% |
| Q3 2018 | -62.39% |
| Q2 2018 | 361.24% |
| Q1 2018 | -10.58% |
| Q4 2017 | -13.73% |
| Q3 2017 | 0.11% |
| Q2 2017 | 7.97% |
| Q1 2017 | -53.60% |
| Q4 2016 | 152.06% |
| Q3 2016 | 28.76% |
| Q2 2016 | -77.69% |
| Q1 2016 | 403.07% |